(Q54071069)

24 May 2018

title

Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo. (English)

1 reference

24 May 2018

1 reference

Yudkin JS

1

1 reference

24 May 2018

Coppack SW

2

1 reference

24 May 2018

Bulmer K

3

1 reference

24 May 2018

Rawesh A

4

1 reference

24 May 2018

Mohamed-Ali V

5

1 reference

24 May 2018

publication date

1 October 1999

1 reference

24 May 2018

published in

Thrombosis Research

1 reference

24 May 2018

volume

96

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

1-9

1 reference

24 May 2018

Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

R.D. Lawrence Lecture 1995 Mrs Sprat's diabetes: some metabolic insights

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Metabolic characteristics of human adipose tissue in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Relationships of generalized and regional adiposity to insulin sensitivity in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900061-4

7 January 2021

10.1016/S0049-3848(99)00061-4

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2aywrrsmpzgk5nx2y6bxjh2fne

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_2aywrrsmpzgk5nx2y6bxjh2fne

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2aywrrsmpzgk5nx2y6bxjh2fne

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/2aywrrsmpzgk5nx2y6bxjh2fne

1 reference

30 July 2022